| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 116.503 | 121.393 | 105.212 | 107.946 | 109.749 | 110.190 | 129.416 | 134.957 | 155.824 | 144.808 |
| Total Income - EUR | 117.446 | 122.869 | 106.772 | 108.716 | 111.284 | 113.376 | 130.333 | 139.292 | 159.421 | 146.031 |
| Total Expenses - EUR | 128.025 | 130.751 | 143.072 | 97.343 | 104.470 | 91.752 | 107.660 | 111.640 | 139.784 | 138.964 |
| Gross Profit/Loss - EUR | -10.579 | -7.883 | -36.300 | 11.373 | 6.814 | 21.624 | 22.673 | 27.652 | 19.637 | 7.068 |
| Net Profit/Loss - EUR | -12.991 | -10.326 | -37.299 | 10.294 | 3.499 | 18.603 | 18.790 | 24.185 | 16.074 | 5.140 |
| Employees | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Amc Pharma Solutions Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.779 | 3.380 | 1.038 | 660 | 357 | 707 | 1.384 | 654 | 18.601 | 14.781 |
| Current Assets | 110.886 | 108.835 | 46.892 | 59.859 | 75.666 | 90.176 | 135.349 | 138.205 | 115.654 | 141.573 |
| Inventories | 51.117 | 56.108 | 20.078 | 15.343 | 37.033 | 60.364 | 97.083 | 96.775 | 68.336 | 116.592 |
| Receivables | 53.770 | 45.276 | 26.578 | 43.550 | 36.295 | 28.314 | 29.175 | 38.283 | 42.623 | 16.415 |
| Cash | 5.999 | 7.451 | 237 | 966 | 2.338 | 1.498 | 9.091 | 3.147 | 4.695 | 8.566 |
| Shareholders Funds | 46.469 | 35.669 | -2.234 | 8.101 | 3.549 | 22.085 | 40.385 | 64.696 | 80.574 | 58.810 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 73.787 | 77.011 | 50.655 | 52.994 | 72.919 | 69.040 | 96.423 | 74.180 | 78.016 | 97.637 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Amc Pharma Solutions Srl